SAVE THE DATE
This course will be held again on
April 24 – 28, 2022.
Information contained in this site is for the 2021 program.
Information for the 2022 program not yet available.
Comprehensive Updates for State-of-the-Art Evaluation, Diagnosis, and Treatment
Pulmonary and Critical Care Medicine will be held online this year, using live streaming, electronic Q&A, and other remote learning technologies.
This comprehensive course provides education and updates to optimize your care of patients with:
- Chronic cough
- Lung nodules
- Lung cancer
- Sleep apnea
- Pleural Disease
- Surgical emergencies
- Lung transplantation
- Neurologic issues in the ICU
- Septic shock
- Interstitial lung disease
- Cystic fibrosis
- Atypical mycobacterial disease
- Pulmonary hypertension
- Cardiopulmonary disorders
- Complications from cardiac arrest
- Hypersensitivity pneumonitis
- Occupational and environmental lung disease
- Acute respiratory failure
- Vaping-related lung disease
- Hemorrhage and ANCA-associated disease
REASONS TO ATTEND IN 2021
All sessions are led by master clinicians who deliver information in inspiring and entertaining ways, and provide specific recommendations to incorporate the latest updates into your practice, including:
- Comprehensive updates on COVID-19
- High-flow oxygen therapy for respiratory failure
- Lung microbiome: emerging implications for lung health
- Evaluating occupational and environmental lung disease
- Prescribing medications for interstitial lung disease
- Pulmonary embolus: the latest treatment strategies
- Guidance to conduct end-of-life discussions
- Updates in pulmonary pathology
- New treatment options in cystic fibrosis
- Thoracic ultrasound in critical care
- Handling neurologic and surgical emergencies in the medical ICU
- The state of the art in interventional bronchoscopy
- The most current guidelines for treating sepsis
- Evidence-based treatment of ARDS
- Updates on vaping-related lung disease
- Best practices to apply the newest asthma and COPD biologics
- Guidance to navigate controversies surrounding therapeutic hypothermia and post-cardiac arrest prognosis
- New approaches that improve outcomes for patients with unexplained chronic cough
- Current guidelines for management of pulmonary nodules
- Targeted therapies and immunotherapies for lung cancer
- When to consider lung transplantation
- When and how to use the newest drugs in IPF
- Expert advice on atypical mycobacterial diagnostics and therapy
- New concepts in the use of vasopressors in septic shock
- New drugs and combinations in pulmonary hypertension
- Advanced techniques in interventional pulmonology
- The latest on sedation, analgesia, and early mobility
Participants also get a glimpse into the future of the field with short talks given by world-renowned experts on exciting, cutting-edge topics.
Special Half-Day Update
Care of COVID-19 and Post-COVID-19 Patients
The pulmonary and critical care clinical faculty at Harvard Medical School and Massachusetts General Hospital (MGH) have been at the forefront of the medical community’s response to COVID-19 since the pandemic began and have been (and continue to be) influential advisors to state and national governments on issues related to COVID-19. MGH has cared for thousands of hospitalized COVID-19 patients and far more as outpatients. At the peak of New England’s pandemic in the spring of 2020, MGH had more than 400 hospitalized COVID-19 patients – with more than half of those in the ICU.
This special half-day update shares the clinical practices now employed at MGH in both inpatient and outpatient settings, developed from this faculty’s deep and broad experiences responding to the virus. These practices include:
- Caring for COVID-19 patients in all phases of their illness
- Implementing effective infection control measures
- Implementing new therapies in real time
- Capacity planning and preparation
Faculty also provide up-to-date reviews of:
- What is now known about post-COVID-19 syndrome
- Critical illness manifestations of COVID-19
- Breaking clinical trials results in COVID-19
The faculty welcome your specific questions in this program’s expanded Q&A section.
Optional Half-Day Program
(No additional fees apply)
Sleep Medicine for Pulmonologists
This sleep medicine program provides pulmonologists the opportunity to learn about recent advances in Sleep Medicine and how they impact clinical practice.
Offered on Thursday morning, April 29, participants of Pulmonology and Critical Care Medicine 2021 can participate in this half-day program at no additional cost.
Highlights of this practical, interactive educational experience include:
- Updates for diagnosis and management of sleep-disordered breathing
- State-of-the-art management algorithms
- New technologies vs. the “gold standard” polysomnogram
- Reimbursement and telemedicine
- Improved adherence to therapy
Led by Harvard Medical School’s James Mojica, MD, a nationally and internationally recognized specialist in both Pulmonology and Sleep Medicine, participants will leave with specific recommendations to improve the clinical care of patients with sleep disorders.